Does IMATINIB Cause Leukaemia recurrent? 138 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 138 reports of Leukaemia recurrent have been filed in association with IMATINIB (Imatinib). This represents 0.3% of all adverse event reports for IMATINIB.
138
Reports of Leukaemia recurrent with IMATINIB
0.3%
of all IMATINIB reports
55
Deaths
19
Hospitalizations
How Dangerous Is Leukaemia recurrent From IMATINIB?
Of the 138 reports, 55 (39.9%) resulted in death, 19 (13.8%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Leukaemia recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 138 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Leukaemia recurrent?
METHOTREXATE (169)
CYTARABINE (146)
CYCLOPHOSPHAMIDE (134)
FLUDARABINE (107)
VINCRISTINE (103)
DEXAMETHASONE (91)
VENETOCLAX (81)
TRETINOIN (75)
DASATINIB (70)
PONATINIB (66)
Which IMATINIB Alternatives Have Lower Leukaemia recurrent Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL